| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/25/2007 | CN101005828A Compositions comprising a mucoadhesive protein and an activeprinciple for mucosal delivery of said agents |
| 07/25/2007 | CN101005760A A method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor |
| 07/25/2007 | CN101003827A Method for preparing bioactive peptide of collagen from squid skin, and application |
| 07/25/2007 | CN101003814A Constructing and expressing method for expression plasmid of recombined PEX pronucleus of human |
| 07/25/2007 | CN101003805A C100F58 gene of human, its coding proteins, and application |
| 07/25/2007 | CN101003800A Cloning using donor nuclei from non-serum starved, differentiated cells |
| 07/25/2007 | CN101003796A Thrombin |
| 07/25/2007 | CN101003788A Anti tumor translocation peptide of scorpion, preparation method and application |
| 07/25/2007 | CN101003574A Recombined expression of peptide for lowering blood sugar in long acting, and application in medication for treating diabetes |
| 07/25/2007 | CN101003573A Human antibodies that bind human tnfalpha |
| 07/25/2007 | CN101003569A Antigen epitope and mutant of lyase in gamma bacteriophage of anthrax bacillus, and application |
| 07/25/2007 | CN101003568A Recombined diphtheria toxin, preparation method, and application |
| 07/25/2007 | CN101003567A Undecapeptide and application |
| 07/25/2007 | CN101003566A Inhibition peptide in domain of polymerase protein of hepatitis b virus, and application |
| 07/25/2007 | CN101002946A Medicine for treating tumor, and its application |
| 07/25/2007 | CN101002945A Novel complexus used for treating tumor |
| 07/25/2007 | CN101002944A Conjugate of branched chair polymacrogol-interferon, and its preparing method |
| 07/25/2007 | CN101002943A Conjugate of branched chain PEG-GCSF and PEG-GMCSF, and its preparing method |
| 07/25/2007 | CN101002935A Compound traditional Chinese medicine powder for treating pain in waist and lower extremities |
| 07/25/2007 | CN101002934A Compound cardiografin slow-releasing preparation for treating posto-lymphatic fistula and pancreas fistula, and its preparing method |
| 07/25/2007 | CN101002933A Honeysuckle polypeptide, its preparing method and use |
| 07/25/2007 | CN101002932A Tuckahoe polypeptide, its preparing method and use |
| 07/25/2007 | CN101002931A Ubenimex tablet and its preparing method |
| 07/25/2007 | CN101002930A Medicine composition containing aniracetam and brain protein hydrolyte |
| 07/25/2007 | CN101002735A Recombination interleukin-2 frozen-dried preparation, and its preparing method |
| 07/25/2007 | CN101002549A Transgenic non-human animals capable of producing heterologous antibodies |
| 07/24/2007 | US7247718 Polypeptide which is not expressed on normal, mature myeloid cells, for isolating cell suspensions from human blood and marrow for use in bone marrow transplantation, gene therapy and in treating diseases |
| 07/24/2007 | US7247717 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/24/2007 | US7247716 Recombinant sequence, its preparation and use |
| 07/24/2007 | US7247715 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 07/24/2007 | US7247712 Complex of hepatitis B virus-specific antigenic peptides associated with heat shock proteins and the application thereof |
| 07/24/2007 | US7247709 Mitogenic oxygenases |
| 07/24/2007 | US7247708 Modified vitamin K-dependent polypeptides |
| 07/24/2007 | US7247707 Albumin-free factor VIII formulations |
| 07/24/2007 | US7247705 Proteins having glucose transporter activity |
| 07/24/2007 | US7247704 Multifunctional protease inhibitors and their use in treatment of disease |
| 07/24/2007 | US7247703 Anticancer agents; protein complex |
| 07/24/2007 | US7247702 Periocular drug delivery for diabetic retinopathy |
| 07/24/2007 | US7247701 Amino amides, peptides and peptidomimetics |
| 07/24/2007 | US7247700 BID polypeptides and methods of inducing apoptosis |
| 07/24/2007 | US7247620 preventive therapy using nucleic acid coding a protein |
| 07/24/2007 | US7247618 Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |
| 07/24/2007 | US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents |
| 07/24/2007 | US7247614 Composition and method for modulating somatolactogenic function |
| 07/24/2007 | US7247612 novel cell surface molecules of mammals |
| 07/24/2007 | US7247611 Controlling cell migration; angiogenesis inhibitors; ovulation; antiinflammatory agents; antitumor agents; anticancer agents |
| 07/24/2007 | US7247608 FGF homolog polypeptides |
| 07/24/2007 | US7247479 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease |
| 07/24/2007 | US7247452 Isolated polynucleotide; increased biological activity, decreased cytotoxicity as compared to a mature, recombinant, full length KGF expressed in an insect cell expression system |
| 07/24/2007 | US7247451 administering to a mammal an effective amount of an anti-thrombin protein from the salivary glands of the species, low toxicity, little or no antigenicity, short clearance time from circulation |
| 07/24/2007 | US7247447 Methods to obtain and use such proteins, antibodies, and inhibitory compounds; treating flea infestations in animals; biological pest control |
| 07/24/2007 | US7247446 PRO34128 nucleic acids |
| 07/24/2007 | US7247445 2-O sulfatase compositions and methods of hydrolyzing therewith |
| 07/24/2007 | US7247444 Use of interleukin-19 to treat cervical cancer |
| 07/24/2007 | US7247438 Methods of identifying agents which enhance caspase activity |
| 07/24/2007 | US7247331 Isolating milk proteins by passing milk or whey over a cation-exchange resin, eluting the fraction retained by an aqueous salted solution and desalting and sterilizing the eluate; pharmaceutical and food compositions |
| 07/24/2007 | US7247306 Bacteria strain and bacteriocin produced therefrom |
| 07/24/2007 | US7247300 Therapeutic use of soluble CD39L3 |
| 07/24/2007 | US7247299 Heat resistance; controlling Clostridium, Campylobacter, Streptococcus; gastrointestinal disorders; bactericides |
| 07/24/2007 | US7247297 Use of DF3/MUC1 regulated expression in gene therapy |
| 07/24/2007 | CA2411277C Neurotoxin implant |
| 07/24/2007 | CA2246429C Erbb3 antibodies |
| 07/24/2007 | CA2172777C Use of a cgrp antagonist for the treatment of neurogenic skin redness; composition thus produced |
| 07/24/2007 | CA2151236C Stably transfected cell lines expressing gaba-a receptors |
| 07/24/2007 | CA2133995C Method and composition for the treatment of disorders involving immunological dysfunction |
| 07/24/2007 | CA2121798C Novel cytokine |
| 07/24/2007 | CA1341536C Transforming growth factor peptides |
| 07/24/2007 | CA1341535C Transforming growth factor peptides |
| 07/19/2007 | WO2007082206A2 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 07/19/2007 | WO2007082177A2 Myeloid suppressor cells, methods for preparing them, and methods for using them for treating autoimmunity |
| 07/19/2007 | WO2007082068A2 Methods and compositions for treating asthma in human and non human primates |
| 07/19/2007 | WO2007082052A2 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 07/19/2007 | WO2007081975A2 Method of treating multiple sclerosis |
| 07/19/2007 | WO2007081974A2 Viral hepatitis treatment |
| 07/19/2007 | WO2007081824A2 Fibrillation resistant proteins |
| 07/19/2007 | WO2007081792A2 Methods and compositions related to improving properties of pharmacological agents targeting nervous system |
| 07/19/2007 | WO2007081751A2 Compositions and methods for the treatment of cancer |
| 07/19/2007 | WO2007081654A2 Compositions and methods to enhance viability and function of islet cells |
| 07/19/2007 | WO2007081516A2 Tumor activated prodrugs |
| 07/19/2007 | WO2007081486A2 Oral administration of defensins to treat intestinal diseases |
| 07/19/2007 | WO2007081419A2 Compositions and methods related to anti-fgf agents |
| 07/19/2007 | WO2007081332A1 Cystine-knot fold cytokine |
| 07/19/2007 | WO2007081321A1 Ac2993 lar dosing regimen |
| 07/19/2007 | WO2007080962A1 Anti-inflammatory composition and method for production of anti-inflammatory composition |
| 07/19/2007 | WO2007080942A1 ORAL COMPOSITION CONTAINING INTERFERON-α |
| 07/19/2007 | WO2007080898A1 Sustained-release hydrogel preparation |
| 07/19/2007 | WO2007080847A1 Mutant growth factor with altered receptor specificity and pharmaceutical composition containing the same |
| 07/19/2007 | WO2007080276A1 Thrombin-free biological adhesive and use thereof as a medicament |
| 07/19/2007 | WO2007080201A1 Use of low doses of igf-i in ageing, owing to the neuroprotective, antioxidant and anabolic effects thereof |
| 07/19/2007 | WO2007080129A1 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction |
| 07/19/2007 | WO2007079977A2 Nutraceutical compositions comprising tripeptides |
| 07/19/2007 | WO2007079886A1 Octanoate-reduced human albumin |
| 07/19/2007 | WO2007079753A2 Mutant deoxyadenosine kinase enzymes and their use |
| 07/19/2007 | WO2007079605A2 Template-fixed peptidomimetics with antimicrobial activity |
| 07/19/2007 | WO2007079597A1 Template - fixed peptidomimetics with antimicrobial activity |
| 07/19/2007 | WO2007079592A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| 07/19/2007 | WO2007065156A3 Pharmaceutical formulation for increased epithelial permeability of glucose-regulating peptide |
| 07/19/2007 | WO2007054600A3 Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination |
| 07/19/2007 | WO2007054203A3 Enzyme/substrate system for generating hydrogen peroxide containing sorbitol oxidase consisting of streptomyces c0elic0l0r and sorbitol |
| 07/19/2007 | WO2007045251A3 A composition comprising a coupled enzyme system |